{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:59:07Z","timestamp":1791219547512,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":6738,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1111\/j.1538-7836.2004.00805.x","type":"journal-article","created":{"date-parts":[[2004,11,15]],"date-time":"2004-11-15T12:07:50Z","timestamp":1100520470000},"page":"1118-1126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb\u2010IIIa antagonists"],"prefix":"10.1016","volume":"2","author":[{"given":"O.","family":"Morel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hugel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Jesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Mallat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u2010P.","family":"Douchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zupan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Chauvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u2010P.","family":"Cazenave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tedgui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u2010M.","family":"Freyssinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Toti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0010","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.CIR.99.3.348","article-title":"Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity","volume":"99","author":"Mallat","year":"1999","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0015","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.101.8.841","article-title":"Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes","volume":"101","author":"Mallat","year":"2000","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0020","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1172\/JCI119317","article-title":"The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV\u20101 infection","volume":"99","author":"Aupeix","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0025","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1182\/blood.V99.11.3962","article-title":"Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor\u2010dependent procoagulant activity","volume":"99","author":"Sabatier","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0030","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1055\/s-0037-1616132","article-title":"Flow cytometry detection of platelet procoagulation activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation","volume":"86","author":"Vidal","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0035","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0002-8703(03)00103-0","article-title":"High levels of circulating endothelial microparticles in patients with acute coronary syndromes","volume":"145","author":"Bernal\u2010Mizrachi","year":"2003","journal-title":"Am Heart J"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0040","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/hh1001.090571","article-title":"Current perspective on the role of apoptosis in atherothrombotic disease","volume":"88","author":"Mallat","year":"2001","journal-title":"Circ Res"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0045","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1096\/fj.02-0574fje","article-title":"Intravascular tissue factors initiates coagulation via circulating microvesicles and platelets","volume":"17","author":"Muller","year":"2003","journal-title":"FASEB J"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0050","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1046\/j.1538-7836.2003.00456.x","article-title":"Human cell\u2010derived microparticles promote thrombus formation in vivo in a tissue factor\u2010dependent manner","volume":"1","author":"Biro","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0055","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0735-1097(01)01290-6","article-title":"Long\u2010term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention","volume":"37","author":"Anderson","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0060","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0735-1097(03)00917-3","article-title":"Outcome of urgent and elective percutaneous coronary interventions after pharmacological reperfusion with tenecteplase combined with unfractionned heparin, enoxaparin, or abciximab","volume":"42","author":"Dubois","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0065","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(01)05775-0","article-title":"Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionned heparin: the ASSENT\u20103 randomised trial in acute myocardial infarction","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0070","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1172\/JCI118859","article-title":"Inhibition of platelet\u2010mediated, tissue factor\u2010induced thrombin generation by the mouse\/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and \u2018clinical restenosis\u2019","volume":"98","author":"Reverter","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0075","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1046\/j.1538-7836.2003.00349.x","article-title":"Different effects of various anti\u2010GPIIb\u2010IIIa agents on shear induced platelet activation and expression of procoagulant activity","volume":"1","author":"Goto","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0080","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1055\/s-0037-1616131","article-title":"Increased platelet glycoprotein V levels in patients with coronary and peripheral atherosclerosis\u2014the influence of aspirin and cigarette smoking","volume":"86","author":"Blann","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0085","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1182\/blood.V99.8.2794","article-title":"Coronary no\u2010reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque","volume":"99","author":"Bonderman","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0090","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood.V98.9.2726","article-title":"Thrombogenic potential of human coronary atherosclerotic plaques","volume":"98","author":"Ardissino","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/01.CIR.93.2.229","article-title":"Platelet function in acute myocardial infarction treated with direct angioplasty","volume":"93","author":"Gawaz","year":"1996","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0100","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/blood.V93.10.3451.410k27_3451_3456","article-title":"Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia","volume":"93","author":"Hugel","year":"1999","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1538-7836.2003.00010.x","article-title":"Protective effects of vitamin C on endothelium damage and platelet activation in patients with sustained generation of circulating microparticles","volume":"1","author":"Morel","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0110","doi-asserted-by":"crossref","first-page":"23111","DOI":"10.1074\/jbc.274.33.23111","article-title":"Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway","volume":"274","author":"Mesri","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0115","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0021-9150(01)00433-6","article-title":"High\u2010shear\u2010stress\u2010induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP\u20101 and endothelial cells","volume":"158","author":"Nomura","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0120","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1161\/hc4701.100516","article-title":"Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction","volume":"104","author":"Boulanger","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0125","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1161\/01.STR.0000094425.06242.64","article-title":"Abciximab reduces monocyte tissue factor in carotid angioplasty and stenting","volume":"34","author":"Kopp","year":"2003","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0130","first-page":"443","article-title":"Activated polymorphonuclear leukocytes enhance production of leukocyte microparticles with increased adhesion molecules in patients with sepsis","volume":"52","author":"Fujimi","year":"2002","journal-title":"J Trauma"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0135","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.4049\/jimmunol.161.8.4382","article-title":"Endothelial cell activation by leukocyte microparticles","volume":"161","author":"Mesri","year":"1998","journal-title":"J Immunol"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0140","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0741-5214(03)01033-4","article-title":"P\u2010selectin and leukocyte microparticles are associated with venous thrombogenesis","volume":"38","author":"Myers","year":"2003","journal-title":"J Vasc Surg"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0145","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20021868","article-title":"Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticles P\u2010selectin glycoprotein ligand 1 and platelet P\u2010selectin","volume":"197","author":"Falati","year":"2003","journal-title":"J Exp Med"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ni871","article-title":"Serum\u2010derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells","volume":"4","author":"Anderson","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0155","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0008-6363(98)00130-8","article-title":"Procoagulant and proinflammatory activity in acute coronary syndromes","volume":"40","author":"Manten","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0160","doi-asserted-by":"crossref","first-page":"14586","DOI":"10.1016\/S0021-9258(18)82371-7","article-title":"Platelet\u2010derived microparticle formation involves glycoprotein IIb\u2010IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect","volume":"268","author":"Gemmell","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1365-2141.2001.02721.x","article-title":"Greater inhibition of platelet procoagulant activity by antibody\u2010derived glycoprotein IIb\u2010IIIa inhibitors than by peptide and peptidomimetic inhibitors","volume":"113","author":"Lages","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0170","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1046\/j.1538-7836.2003.00136.x","article-title":"Abciximab inhibits procoagulant activity but not the release reaction upon collagen\u2010 or clot\u2010adherent platelets","volume":"1","author":"Ilverskero","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0175","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00005344-200303000-00004","article-title":"Comparison of shear stress\u2010induced platelet microparticle formation and phosphatidylserine expression in presence of alpha IIb beta3 antagonists","volume":"41","author":"Haga","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0180","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1055\/s-0037-1614050","article-title":"GPIIb\u2010IIIa antagonist\u2010induced reduction in platelet surface factor V\/Va binding and phosphatidylserine expression in whole blood","volume":"84","author":"Furman","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0185","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00001721-200312000-00005","article-title":"Increased generation of platelet\u2010derived microparticles following percutaneous transluminal coronary angioplasty","volume":"14","author":"Craft","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.CIR.104.2.163","article-title":"Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization","volume":"104","author":"Lincoff","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0195","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1172\/JCI2592","article-title":"Modulation of monocyte\u2013endothelial cell interactions by platelet microparticles","volume":"102","author":"Barry","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0049-3848(02)00207-4","article-title":"The GPIIb\/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac\u20101 (CD11b\/CD18, alphaMbeta2)","volume":"107","author":"Schwarz","year":"2002","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0205","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood.V92.9.3268","article-title":"Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin alphavbeta3 antagonist and inducing apoptosis","volume":"92","author":"Yeh","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0210","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/01.CIR.0000019905.18467.07","article-title":"Abciximab attenuates coronary microvascular endothelial dysfunction after coronary stenting","volume":"105","author":"Aymong","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0215","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0735-1097(01)01165-2","article-title":"Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting","volume":"37","author":"Neumann","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0220","doi-asserted-by":"crossref","first-page":"23C","DOI":"10.1016\/S0002-9149(00)00876-6","article-title":"IIb's are not IIb's","volume":"85","author":"Kereiakes","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0225","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0140-6736(98)05848-6","article-title":"Abciximab not RGD peptide inhibits von Willebrand factor\u2010dependent platelet activation under shear","volume":"353","author":"Goto","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0230","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/euhj.2001.3151","article-title":"Does eptifibatide confer a greater benefit to patients with unstable angina than with non\u2010ST segment elevation myocardial infarction? Insights from the PURSUIT Trial","volume":"23","author":"Chang","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0235","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1055\/s-0037-1613127","article-title":"An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates","volume":"87","author":"Marciniak","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0240","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1182\/blood.V96.7.2469","article-title":"The GPIb thrombin\u2010binding site is essential for thrombin\u2010induced platelet procoagulant activity","volume":"96","author":"Dormann","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0245","doi-asserted-by":"crossref","first-page":"27183","DOI":"10.1074\/jbc.272.43.27183","article-title":"Networking in the hemostatic system. Integrin alphaiibbeta3 binds prothrombin and influences its activation","volume":"272","author":"Byzova","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0250","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.CIR.0000053559.46158.AD","article-title":"Inhibitory effects of glycoprotein IIb\/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation","volume":"107","author":"Nannizzi\u2010Alaimo","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2004.00805.x_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9343(02)01145-2","article-title":"Multi\u2010year follow\u2010up of abciximab therapy in three randomized, placebo\u2010 controlled trials of percutaneous coronary revascularization","volume":"113","author":"Topol","year":"2002","journal-title":"Am J Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2004.00805.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622180232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622180232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2004.00805.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:31:32Z","timestamp":1761532292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622180232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S1538783622180232"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00805.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb\u2010IIIa antagonists","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00805.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}